中心静脉输液港用于增强CT的实践:与周围静脉通路在强化效果和安全性方面的比较
本研究比较中心静脉输液港(CV港)与周围静脉通路(PA)在门静脉期增强CT中的强化效果与安全性。CV延迟组门静脉密度显著低于PA组(165.7±20.1 vs 181±19 HU,p<0.01),而CV常规组与PA组无显著差异(p>0.05)。119次经CV港高压注射未发生相关并发症,CV港可安全用于对比剂注射并维持与PA相当的门静脉期强化。
要点
- CV港高压注射119次无相关并发症,可安全用于增强CT对比剂注射。
- CV常规方案与周围静脉通路门静脉期强化无显著差异(p>0.05)。
- CV延迟组门静脉密度显著低于PA组(165.7±20.1 vs 181±19 HU,p<0.01)。
核心结论
- CV港可安全用于对比剂注射,门静脉期强化效果与周围静脉通路相当。
研究设计与样本
- 将患者分为CV延迟组、CV常规组和周围静脉通路(PA)组,比较门静脉期强化与峰值注射压力;CV延迟组采用手臂下垂位并额外延迟注射,CV常规组和PA组按常规门静脉期方案注射;共经CV港装置完成119次对比剂注射。
诊断标准与关键数值
- 强化评估指标为主动脉弓、腹主动脉、下腔静脉、门静脉和脾脏的平均放射密度(HU);CV延迟组门静脉165.7±20.1 HU vs PA组181±19 HU(p<0.01),CV常规组与PA组各部位平均放射密度无显著差异(p>0.05)。
临床应用与阅片要点
- CV常规组与PA组门静脉期强化无显著差异;CV延迟组门静脉密度显著低于PA组(p<0.01);CV延迟组、CV常规组和PA组峰值注射压力中位数分别为73.5、67和47 psi(p<0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the efficacy of using the central venous (CV) port compared with peripheral intravenous access for contrast-material injection for contrast enhancement during the portal venous phase.
MATERIALS AND METHODS: Patients were divided into three groups: CV delay, CV routine, and peripheral access (PA) groups. Patients in the CV delay group underwent injection in the arm-down position with an additional delay, while those in the CV routine and PA groups underwent injections with the routine injection protocol for portal venous phase imaging. Contrast enhancement was evaluated by measuring the mean radiodensity (Hounsfield units) values for the aortic arch, abdominal aorta, inferior vena cava, portal vein, and spleen. The peak injection pressure was recorded and compared among the three groups.
RESULTS: No complications related to power injection were observed during 119 contrast-material injections performed using the CV port device. The CV delay group showed significantly lower radiodensity values than the PA group (165.7 ± 20.1 versus 181 ± 19 HU [p<0.01] for the portal vein); however, no significant differences in mean radiodensity values were observed between the CV routine and PA groups (p>0.05). The median peak injection pressure was 73.5, 67, and 47 psi in the CV delay, CV routine, and PA groups, respectively (p<0.01).
CONCLUSION: The CV port can be used for safe contrast-material injection while maintaining contrast enhancement on portal venous phase comparable to that achieved with peripheral intravenous access.
引用
- Washio H, Kashimoto K, Sakashita N, et al. Practical use of the central venous access port for contrast-enhanced CT: comparison with peripheral intravenous access regarding enhancement and safety. Clin Radiol. 2024. PMID: 38218706. doi:10.1016/j.crad.2023.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。